BioFactura, Inc. Email Format
Biotechnology ResearchMaryland, United States11-50 Employees
BioFactura, Inc. operates in the biotechnology research sector, focusing on the development and commercialization of biodefense drugs, novel therapeutics, and high-value biosimilars for autoimmune and infectious diseases. Its offerings are positioned to address needs in defense against biological threats as well as broader medical applications, including cancer therapies and biosimilar products, with an emphasis on manufacturing processes that aim for faster, lower-cost, high-quality production. Headquartered in Frederick, Maryland, BioFactura has developed its StableFast Biomanufacturing Platform to support its drug development and production programs. The company collaborates with partners and markets its products to clients seeking advanced biodefense solutions, novel medicines, and biosimilars, including arrangements related to exclusive licenses and strategic partnerships. The organization has a multi-year focus on advancing therapies from research to patient access in the biotechnology landscape.